Introduction {#Sec1}
============

Obsessive-compulsive disorder (OCD) is characterized by recurrent intrusive thoughts or images (obsessions) and/or ritualized behaviours (compulsions) that cause marked distress and impairment to a person^[@CR1]^. About 1--3% of the general population suffers from OCD^[@CR2]--[@CR5]^ and the symptoms appear before age 25 years in about two-thirds of affected persons, with the mean age of onset about 20 years^[@CR2],[@CR4]^. Both environmental and genetic factors are deemed to play important roles in the aetiology of OCD and genetic factors account for about 45--65% of variance in OCD if the disorder occurs in childhood^[@CR6]^. Despite the great progress made in understanding the pathogenesis of the disorder, the genetic causes of OCD remain elusive. This may be because the aetiology of OCD is complex and probably related with multiple independent and interacting genetic factors.

The completion of the Human Genome Project and the development of genome-wide screening have made microarray technology an important tool to study genetic effects on the aetiology of psychiatric disorders^[@CR7]^. Previous studies have found genes in blood and brain tissues share similar expression patterns^[@CR8],[@CR9]^, and it is easier to measure gene expression in blood because it can be obtained with minimal invasiveness. Microarray approaches have been widely used to investigate neuropsychiatric disorders such as schizophrenia^[@CR10]^, bipolar disorder^[@CR11]^, and major depressive disorder (MDD)^[@CR12]^. In addition, microarray data have been used to find novel genes and pathways that may be related with the aetiology of psychiatric disorders^[@CR7]^. However, to our knowledge, microarrays have not been applied to investigate gene expression in the peripheral blood of OCD patients. In this study, we aimed to detect genes (mRNAs) that were differentially expressed between patients with OCD and healthy controls using microarray technology. We also performed an enrichment analysis of the gene ontology (GO) terms and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways assigned to the genes to investigate the functions of the differentially expressed mRNAs.

Results {#Sec2}
=======

Differentially expressed mRNAs {#Sec3}
------------------------------

We used microarrays in a genome-wide scan of mRNAs from peripheral blood mononuclear cells (PBMCs) of 30 patients with OCD and 30 paired healthy controls.

We detected a total of 51 differentially expressed mRNAs with fold change ≥1.5 and false discovery rate \<0.05; 45 were down-regulated and 6 were up-regulated (Table [1](#Tab1){ref-type="table"}, Fig. [1](#Fig1){ref-type="fig"}). The hierarchical cluster analysis showed that the samples separated into distinct patient and control groups (Fig. [2](#Fig2){ref-type="fig"}).Table 1All the differentially expressed genes (Benjamini-Hochberg adjusted *p*-value \< 0.05) detected between the OCD patients and healthy controls with current NCBI Entrez gene records.Gene SymbolGene NameChromosomeregulationp ValueFold changeFDR1RPL27ribosomal protein L27chr17down6.91E-070.5827629480.0031872RPS18ribosomal protein S18chr6down5.72E-070.6107880040.0031873RPL26ribosomal protein L26chr17down4.42E-060.424817140.0035464COMMD6COMM domain containing 6chr13down2.76E-060.4272942990.0035465RPL34ribosomal protein L34chr4down3.24E-060.4458848090.0035466RPS7ribosomal protein S7chr2down3.24E-060.4586317490.0035467RPL31ribosomal protein L31chr2down4.42E-060.5014109420.0035468RPL39ribosomal protein L39chrXdown3.79E-060.5396141890.0035469TOMM7translocase of outer mitochondrial membrane 7 homolog (yeast)chr7down3.79E-060.5421382270.00354610EEF1B2eukaryotic translation elongation factor 1 beta 2chr2down4.42E-060.5566889070.00354611RPS15Aribosomal protein S15achr16down2.35E-060.5620207560.00354612RGS4regulator of G-protein signaling 4chr1down3.79E-060.5664139390.00354613RPL35ribosomal protein L35chr9down2.35E-060.590629580.00354614RPS29ribosomal protein S29chr14down2.76E-060.5963786920.00354615SNRPD2small nuclear ribonucleoprotein D2 polypeptide 16.5 kDachr19down2.35E-060.6314751090.00354616RPL35Aribosomal protein L35achr3down1.42E-060.6481756220.00354617RPL6ribosomal protein L6chr12down3.79E-060.6527100160.00354618RPS24ribosomal protein S24chr10down5.14E-060.4506041380.00379619RPL17ribosomal protein L17chr18down5.97E-060.5130454760.00393520RPL23ribosomal protein L23chr17down6.92E-060.4957247750.00425421RPS17ribosomal protein S17chr15down6.92E-060.5229416990.00425422RPL41ribosomal protein L41chr12down1.06E-050.4830012020.00477323RPL11ribosomal protein L11chr1down1.06E-050.6649637570.00477324RPS21ribosomal protein S21chr20down1.22E-050.6569730820.00522625PFDN5prefoldin subunit 5chr12down1.40E-050.5238570140.00585526RPL21ribosomal protein L21chr13down1.82E-050.6033597860.00647227RPL7ribosomal protein L7chr8down2.08E-050.4969594210.00671628RPS27ribosomal protein S27chr1down2.37E-050.5252599840.00671629COX7Ccytochrome c oxidase subunit VIIcchr5down2.37E-050.6316209330.00671630NDUFA4NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9 kDachr7down2.08E-050.6619014040.00671631UQCRBubiquinol-cytochrome c reductase binding proteinchr8down2.69E-050.513081110.00698532TAS2R46taste receptor, type 2, member 46chr12up2.69E-051.7558543990.00698533CD52CD52 moleculechr1down2.69E-050.6302998470.00698534OCR1ovarian cancer-related protein 1chr1up3.05E-051.7217991540.00760235RPS3Aribosomal protein S3Achr4down3.90E-050.4968053640.00857336RPL9ribosomal protein L9chr4down5.59E-050.5546583370.01021437NDUFA1NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5 kDachrXdown5.59E-050.6518533570.01021438XRCC6BP1XRCC6 binding protein 1chr12down8.86E-050.6216417410.01296639HINT1histidine triad nucleotide binding protein 1chr5down9.90E-050.6593651250.01314140KLRB1killer cell lectin-like receptor subfamily B, member 1chr12down0.0001530.6400294770.01575341MANSC1MANSC domain containing 1chr12up0.0001531.5520733680.01575342TAS2R30taste receptor, type 2, member 30chr12up0.0001531.5075790760.01575343RPL22L1ribosomal protein L22-like 1chr3down0.000380.5985401110.02460144COMMD8COMM domain containing 8chr4down0.000380.6261336590.02460145NDUFA5NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13 kDachr7down0.000380.6273597580.02460146GZMAgranzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)chr5down0.0006080.6565863120.02984847RPS27Lribosomal protein S27-likechr15down0.0006080.6626139450.02984848MRPS28mitochondrial ribosomal protein S28chr8down0.0006670.6562635510.03089349FBXL13F-box and leucine-rich repeat protein 13chr7up0.0007981.5456022010.03375750ZNF721zinc finger protein 721chr4down0.0011310.4839700740.04005951CACNB4calcium channel, voltage-dependent, beta 4 subunitchr2up0.0011311.6286453690.040059Figure 1Volcano plot of changes in the whole-genome gene expression profiles of peripheral blood mononuclear cells between OCD patients and healthy controls. A total of 51 significantly differentially expressed mRNAs with fold change ≥1.5 and Bonferroni-adjusted *p*-value \< 0.05 were detected. Blue dots indicate the 45 down-regulated genes, red dots indicate the 6 up-regulated genes. The horizontal green line is the negative logarithm of the Bonferroni-adjusted *p*-value threshold.Figure 2Heatmap of the top 100 differentially expressed genes that can distinguish OCD patients and healthy controls obtained by hierarchical cluster analysis.

Functional annotation {#Sec4}
---------------------

The GO functional enrichment analysis revealed 23 of the 51 significantly differentially expressed mRNAs were enriched in ribosomal protein terms, including cellular protein metabolic process, endocrine pancreas development, viral transcription, viral infectious cycle, viral reproduction, gene expression, translation, and RNA binding. The genes encoding NDUFA4 (NADH dehydrogenase (ubiquinone) 1alpha subcomplex), NDUFA5, and NDUFA1 were significantly enriched in mitochondrial electron transport and NADH to ubiquinone, and the genes encoding NDUFA4, COX7C (cytochrome c oxidase subunit VIIc), and UQCRB (ubiquinol-cytochrome c reductase binding protein) were significantly enriched in hydrogen ion transmembrane transport.

The KEGG pathway analysis of the 51 significantly differentially expressed mRNAs also identified 23 mRNAs that were enriched in ribosome; *NDUFA4*, *NDUFA5*, *COX7C*, *NDUFA1*, and *UQCRB*, which were significantly enriched in Parkinson's disease, Alzheimer's disease, Huntington's disease, and non-alcoholic fatty liver disease, and *COX7C*, *CACNB4* (calcium channel, voltage-dependent, beta 4 subunit), and *UQCRB*, which were significantly enriched in cardiac muscle contraction (Table [2](#Tab2){ref-type="table"}).Table 2Functional categories and biological function annotations based on gene ontology (GO) terms and KEGG pathways.CategoryFunctions Annotationp-ValueMoleculesKEGG analysisRibosome8.15E-31RPL35A, RPL17, RPL35, RPS15A, RPS27L, RPL22L1, RPL39, RPS7, RPS27, RPS29, RPL41, RPL7, RPL23, RPS17, RPS3A, RPL31, RPL6, RPL21, RPL9, RPL34, RPL11, RPS21, RPS24Oxidative phosphorylation0.003482NDUFA4, NDUFA5, COX7C, NDUFA1, UQCRBParkinson's disease0.004403NDUFA4, NDUFA5, COX7C, NDUFA1, UQCRBNon-alcoholic fatty liver disease (NAFLD)0.005477NDUFA4, NDUFA5, COX7C, NDUFA1, UQCRBAlzheimer's disease0.00796NDUFA4, NDUFA5, COX7C, NDUFA1, UQCRBHuntington's disease0.012589NDUFA4, NDUFA5, COX7C, NDUFA1, UQCRBCardiac muscle contraction0.04943COX7C, CACNB4, UQCRBGo analysisRibosome2.57E-29RPL35A, RPL17, RPL35, RPS15A, RPS27L, RPL22L1, RPL39, RPS7, RPS27, RPS29, RPL41, RPL7, RPL23, RPS17, RPS3A, RPL31, RPL6, RPL21, RPL9, RPL34, RPL11, RPS21, RPS24mitochondrial electron transport, NADH to ubiquinone0.006979NDUFA4, NDUFA5, NDUFA1hydrogen ion transmembrane transport0.010652NDUFA4, COX7C, UQCRBmitochondrial electron transport, cytochrome c to oxygen0.050016NDUFA4, COX7CSignificant biological pathways with two or more differentially expressed mRNAs representing each function are shown.

Real-time quantitative PCR (qRT-PCR) validation {#Sec5}
-----------------------------------------------

To validate the results of the microarray analysis, we chose 10 differently expressed mRNA transcripts for validation by qRT-PCR, namely, *RPS3A*, *RPL34*, *RPS24*, *RPL23*, *RPS7*, *RPL41*, *RPL7*, *RPL26*, *ZNF721*, and *COMMD6*. The qRT-PCR results showed that *RPL34* was down-regulated consistent with the microarray analysis, whereas *RPS3A*, *RPS24*, *RPL23*, *RPS7*, *RPL41*, *RPL7*, and *RPL26* were up-regulated (Table [3](#Tab3){ref-type="table"}). *ZNF721* and *COMMD6* were not found to be differently expressed between OCD and healthy controls by qRT-PCR (Table [3](#Tab3){ref-type="table"}).Table 3The mRNA expression levels in OCD patients and healthy controls by qRT-PCR.Gene SymbolOCD (n = 26)Healthy controls (n = 26)RegulationP valueFold changeFDR1RPS75.33 ± 3.361.20 ± 1.11up2.576E-074.4572.58E-062RPS3A4.23 ± 3.980.84 ± 0.70up8.292E-055.0660.00043RPL340.14 ± 0.110.33 ± 0.26down0.0010.4220.0024RPS2430.01 ± 26.289.42 ± 14.64up0.0013.1880.0025RPL2313.64 ± 10.986.53 ± 9.00up0.0142.090.0186RPL415.60 ± 5.331.92 ± 3.00up0.0032.9130.0047RPL7186.69 ± 251.2423.61 ± 26.98up0.0027.9090.0038RPL267.22 ± 7.881.45 ± 2.05up0.0014.9710.0029ZNF7210.73 ± 0.710.77 ± 0.81---0.8580.9510.85810COMMD60.45 ± 0.480.61 ± 0.58---0.2990.7460.332

Discussion {#Sec6}
==========

To the best of our knowledge, this is the first study to reveal differentially expressed genes between patients with OCD and healthy controls using mRNA microarray technology. We found 45 mRNAs that were down-regulated and 6 mRNAs that were up-regulated in patients with OCD.

Previous studies have indicated that important genes involved in the pathophysiology of OCD were related to serotonin, dopamine, and glutamate systems^[@CR13]--[@CR15]^; however, we did not detect these genes in the present study. These discrepancies may be explained by the different research methods that were used. In previous studies, candidate gene approaches were used to explore OCD-related genes^[@CR13]--[@CR15]^, whereas we used microarrays to detect genes related to OCD^[@CR16]^. The GO and KEGG analyses revealed 23 differentially expressed mRNAs that were enriched in terms and pathways related with ribosomal proteins (RPs).

Ribosomes are subcellular organelles composed of two different subunits^[@CR17]^, and each subunit contains various numbers of ribosomal RNAs (rRNAs) and RPs. Large 60S ribosomal subunits assemble with small 40S subunits to form 80S ribosomes. In mammals, the 80S ribosomal nucleoprotein complex contains 4 rRNAs and about 80 proteins, with more than 150 associated proteins and about 70 small nucleolar RNAs^[@CR18]^. The small 40S subunit mediates the interactions between tRNAs and mRNA and selects the correct tRNA for the decoding centre. The large 60S subunit harbours the peptidyl transferase centre and provides the exit tunnel for the growing nascent polypeptide chain. Ribosomes function in translating mRNAs into proteins and translation is tightly depended on the ribosome proteins (RPs)^[@CR19]^. RPs are highly conserved, so quantitative deficiencies result in reduced protein synthesis^[@CR20]^, which can affect a range of pathological processes such as cancer^[@CR21]^, genetic diseases^[@CR22]^, and viral infection^[@CR23]^.

RP-encoding genes are widely dispersed. Both human sex chromosomes and the autosomes (all but chromosomes 7 and 21) carry one or more RP genes^[@CR20]^. Disturbance in translational homeostasis was shown to be involved in the pathogenesis of neurodegenerative disorders^[@CR24],[@CR25]^. For example, a decline in the amount of rRNA was found to be associated with the progression of Alzheimer's disease^[@CR26]^. Ribosomes may not be involved only in severe psychiatric disorders. For example, the copy numbers of ribosomal genes were shown to increase in schizophrenia and decrease in autism^[@CR27]^. Mutations in the RP-encoding gene *RPL10* were reported in people with autism^[@CR28]^, but another study did not find changes in *RPL10* expression associated with autism^[@CR29]^. Changes in ribosomes have also been associated with depression. The transcriptional activity of ribosomal DNA was diminished in the argyrophilic nucleolar organizer region of brain tissue of patients with MDD, which suggested hypoactivity of neurons in MDD^[@CR30]^, and another study revealed over-expressed RPs in the hippocampus of a mouse model of MDD^[@CR31]^. In the current study, we found the mRNAs that encoded RPs were down-regulated, which may decrease the number of ribosomes and subsequently reduce protein synthesis. The down-regulation of mRNAs encoding some RPs may only reduce protein synthesis, which is not as drastic as the complete mutation or deletion of an RP gene. This, combined with other unknown factors, potentially could produce the symptoms of OCD.

Members of the zinc finger protein (ZNF) family have DNA- and RNA-binding motifs and the amino acids are folded into a single structural unit around a zinc atom^[@CR32]^. ZNF proteins have a wide-range of functions, including transcription and DNA recognition^[@CR33]^. *ZNF804A* has been identified as one of the most compelling risk genes associated with psychiatric disorders^[@CR34],[@CR35]^. In the current study, we found that the *ZNF721* mRNA was down-regulated in the OCD patients.

COMMD (copper metabolism domain containing) proteins (also known as MURR1) were discovered about 10 years ago, and 10 COMMD proteins are known so far. They are involved in, for example, copper homeostasis, regulating transcription factor NF-κB (nuclear factor κB), and cell proliferation^[@CR36]^. COMMD6, a ubiquitously expressed small soluble protein and endogenous inhibitor of NF-κB, binds DNA and activates transcription^[@CR37],[@CR38]^. Activation of NF-κB has been associated with some neurodegeneration diseases as consequences of the neurotoxic role of NF-κB^[@CR39]^. The down-regulation of *COMMD6* or the action of another NF-κB inhibitor NFKBIA may increase the activation of NF-κB, which might impair the function of the hippocampus in individuals with OCD.

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex (NDUFA4) is the 14th subunit of cytochrome c oxidase. NDUFA4L2 inhibits complex I of oxidative phosphorylation, which is the final oxygen-accepting enzyme complex of the mitochondrial respiratory chain, to mediate a shift to glycolysis in growing cells and cancer tissues^[@CR40]^. The over-expression of *NDUFA4* seen in lung cancer cells is in contrast to its down-regulation in Alzheimer's disease. In a previous genome-wide study, *NDUFA4* was found to be associated with Alzheimer's disease and was identified as a potential biomarker of the disease^[@CR41]^. Ubiquinol cytochrome c reductase binding protein (UQCRB) is important for mitochondrial complex III stability, electron transport, cellular oxygen sensing, and angiogenesis. *NDUFA*, *COX7C*, and *UQCRB* are involved in the mitochondrial respiratory chain, and all three were down-regulated in the OCD patients. However, there is limited knowledge about the relationship between mitochondrial dysfunction and OCD.

The genes encoding type-2 bitter-taste receptors (TAS2R30 and TAS2R46) were up-regulated in OCD. TAS2Rs are expressed widely outside the brain, but their relationship to OCD is not known.

CACNB4 is one of the voltage-gated calcium channel beta subunits, which was recently found to function in neuronal excitability and gene transcription^[@CR42]^. *CACNB4* was over-expressed in schizophrenia and was associated with depressing the calcium currents that drive spine formation and stabilization, and increased *CACNB4* expression was found to drive small spine loss^[@CR43]^. We consider the up-regulation of *CACNB4* detected in our study may be related with the pathogenesis of OCD.

Several limitations in our study should be noted. First, the sample size was relatively small, which may have reduced the statistical power of the comparison of gene expression between the OCD and healthy control groups. There were inconsistencies in the direction of gene alterations between the microarray analysis and the qRT-PCR validation, likely because different samples were used for validation and the patients were at different stages of the disorder and under different treatment regimes.

In conclusion, we detected altered gene expression patterns in patients with OCD and highlighted the role of RP genes in the pathogenesis of OCD.

Materials and Methods {#Sec7}
=====================

Participant profiles {#Sec8}
--------------------

This study was conducted in the Wuxi Mental Health Centre of Nanjing Medical University, Wuxi, Jiangsu Province, China. Thirty patients with OCD and 30 sex- and age-paired healthy controls were recruited. There were 20 males and 10 females in both groups. The mean age was 28.8 ± 12.0 years (range 15--60 years) and 28.8 ± 11.1 years (range 17--56 years) for the patient and the control groups respectively. The diagnosis of OCD was confirmed using the structured clinical interview for DSM-IV disorders (SCID). Patients with schizophrenia, MDD, comorbid axis I disorder, or with a history of neurological disease were excluded. Healthy controls who were free from any psychiatric illness or major medical condition were recruited from the local community.

This study was approved by the human ethics committee of the Wuxi Mental Health Centre of Nanjing Medical University. Written informed consent was provided by each participant. All study procedures were in accordance with the Helsinki Declaration of 1975.

Blood sample collection and PBMC isolation {#Sec9}
------------------------------------------

Peripheral blood was collected in 10-ml vacutainer tubes containing EDTA and immediately stored at 4 °C. Whole blood was processed within 2 h of collection.

Ficoll density gradient centrifugation was used to separate the peripheral blood mononuclear cells (PBMCs). Briefly, saline diluted blood was layered over Ficoll, then centrifuged to separate red blood cells, PBMCs, and plasma. The PBMCs were gently and entirely sucked up from the layer of Ficoll and transferred to a new tube, which was washed twice.

Total RNA isolation {#Sec10}
-------------------

Total RNA was extracted from the PBMCs using TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions and quantified using a NanoDrop ND-2000 (Thermo Scientific). RNA integrity (RIN) was assessed using an Agilent Bioanalyzer 2100 (Agilent Technologies).

The mean (SD) RIN for all the samples was 9.29 (0.48). The 28S to 18S rRNA ratio was 2.79 (0.35) and the RIN was ≥7. For 28S:18S a RIN value ≥0.7 was considered to be within the range of acceptable RNA quality according to the manufacturer's instructions.

mRNA microarray, labelling, hybridization, and scanning {#Sec11}
-------------------------------------------------------

Total RNA was labelled with a mRNA Complete Labelling and Hyb Kit (Agilent Technologies) and hybridized on a Human lncRNA Microarray 4.04 × 180 K (Agilent Technologies). The microarray contains 30,656 probes for human mRNA, all of which were derived from authoritative databases, including RefSeq Build, Ensemble Release, GenBank, and Unigene Build. Total RNA (200 ng each) was reverse transcribed to double-strand cDNA, then synthesized into cRNA and labelled with cyanine-3-CTP. The labelled cRNAs were hybridized to the microarray. After washing, the arrays were scanned using an Agilent Microarray Scanner (G2505C, Agilent Technologies).

Validation by qRT-PCR {#Sec12}
---------------------

Total RNA was isolated from PBMCs from another 26 pairs of OCD and healthy controls using TRIzol reagent (Invitrogen) with on-column DNase I treatment as described by the manufacturer. cDNA was synthesized using a High Capacity RNA-to-cDNA Kit (Invitrogen) according to the manufacturer's instructions. The qRT--PCRs were performed using the primers listed in Table [4](#Tab4){ref-type="table"} and SYBR^®^ Select Master Mix (Invitrogen) on a 7900HT real-time PCR machine (Applied Biosystems, USA) with the following cycles: 2 min at 50 °C, 2 min at 95 °C, then 40 cycles of 15 s at 95 °C, 60 s at 60 °C, followed by a standard dissociation protocol to ensure that each amplicon was a single product. All quantifications were normalized to *ACTB*. The qRT--PCRs were performed in triplicate for each independent sample.Table 4Primers for the differently expressed mRNAs used in the qRT-PCRs.Gene SymbolPrimerPrimer sequences1RPS71-Forwardatgttcagttcgagcgcc1-Reversettcgcgtactagccggac2RPS3A2-Forwardtggcatggatcttacccg2-Reversegatttggcggacctgttg3RPL343-Forwardtgacaggatcaagcgtgc3-Reversettgcagcatttgctgagg4RPS244-Forwardcgccatcatgaacgacac4-Reversegccagttgtcttgccacc5RPL235-Forwardacagacttcccgctgctg5-Reverseaatcatgcaatgctgcca6RPL416-Forwardgaggccacaggagcagaa6-Reverseagaggaccaacatgggca7RPL77-Forwardgcgaaggaatttcgcaga7-Reversettgccagcttttcttgcc8RPL268-Forwardcttccgaccgaagcaaga8-Reversectggggtgaatgcctacg9ZNF7219-Forwardtggacggtacacagccct9-Reversecaaaggctctgccacgat10COMMD610-Forwardggcaatcagaagagtgaggc10-Reversetcgtctttccaactctgcg

Data analysis {#Sec13}
-------------

Agilent Feature Extraction software (version 10.7.1.1; Agilent Technologies) was used to analyse the array images to obtain the raw data. GeneSpring (GX v11.5.1 software package; Agilent Technologies) was employed to analyse the raw data. The raw data were first normalized with the quantile algorithm, followed by differential expression analysis using a student t-test. The probes that had at least 1 out of 2 conditions and had 75% flags in "P" were chosen for further data analysis. Differentially expressed genes were identified based on fold change as well as the *p-*value calculated with the student t-test. The threshold set for up- and down-regulated genes was fold change ≥ 1.5 and false discovery rate ≤ 0.05.

The expression levels of mRNAs between the OCD patients and healthy controls were analysed using the Mann-Whitney U test.

To correlate the differentially expressed mRNAs with biological processes, we annotated the mRNAs with GO terms and KEGG pathways (<http://www.genome.ad.jp/kegg/>) to determine their potential roles. Then, we performed a hierarchical clustering analysis to display the distinguishable gene expression patterns between the OCD and healthy groups. The lower the *p*-value, the more significant the correlation; the recommended *p*-value cut-off was 0.05.
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